The initial public offer or IPO of Metropolis Healthcare opens today and the diagnostics company has fixed a price band in the range of ₹877-880 per share. Metropolis Healthcare IPO consists entirely of an offer for sale of 1.37 crore shares. One of the promoters, Sushil Kanubhai Shah, will offload 63 lakh shares, while investor CA Lotus Investments, part of Carlyle Group, will sell 74 lakh shares through the IPO. RegistrarLink Intime India Private Limited is the registrar of the Metropolis Healthcare IPO offer. Further, Metropolis Healthcare also has better return ratio with RoNW (return on net worth) at 24.7% for FY18 vs. 21.6% for Dr Lal Pathlabs and 20.4% for Thyrocare Tehnologies.

Source: Mint April 02, 2019 13:52 UTC